Literature DB >> 19720167

Metabonomics research of diabetic nephropathy and type 2 diabetes mellitus based on UPLC-oaTOF-MS system.

Jie Zhang1, Lijuan Yan, Wengui Chen, Lin Lin, Xiuyu Song, Xiaomei Yan, Wei Hang, Benli Huang.   

Abstract

Ultra performance liquid chromatography (UPLC) coupled with orthogonal acceleration time-of-flight (oaTOF) mass spectrometry has showed great potential in diabetes research. In this paper, a UPLC-oaTOF-MS system was employed to distinguish the global serum profiles of 8 diabetic nephropathy (DN) patients, 33 type 2 diabetes mellitus (T2DM) patients and 25 healthy volunteers, and tried to find potential biomarkers. The UPLC system produced information-rich chromatograms with typical measured peak widths of 4 s, generating peak capacities of 225 in 15 min. Furthermore, principal component analysis (PCA) was used for group differentiation and marker selection. As shown in the scores plot, the distinct clustering between the patients and controls was observed, and DN and T2DM patients were also separated into two individual groups. Several compounds were tentatively identified based on accurate mass, isotopic pattern and MS/MS information. In addition, significant changes in the serum level of leucine, dihydrosphingosine and phytosphingosine were noted, indicating the perturbations of amino acid metabolism and phospholipid metabolism in diabetic diseases, which having implications in clinical diagnosis and treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19720167     DOI: 10.1016/j.aca.2009.02.027

Source DB:  PubMed          Journal:  Anal Chim Acta        ISSN: 0003-2670            Impact factor:   6.558


  29 in total

1.  Metabolic signature of CKD: the search continues.

Authors:  Anna V Mathew; Subramaniam Pennathur
Journal:  Am J Kidney Dis       Date:  2012-08       Impact factor: 8.860

Review 2.  Perspectives on systems biology applications in diabetic kidney disease.

Authors:  Claudiu V Komorowsky; Frank C Brosius; Subramaniam Pennathur; Matthias Kretzler
Journal:  J Cardiovasc Transl Res       Date:  2012-06-26       Impact factor: 4.132

3.  Metabolomics reveals attenuation of the SLC6A20 kidney transporter in nonhuman primate and mouse models of type 2 diabetes mellitus.

Authors:  Andrew D Patterson; Jessica A Bonzo; Fei Li; Kristopher W Krausz; Gabriel S Eichler; Sadaf Aslam; Xenia Tigno; John N Weinstein; Barbara C Hansen; Jeffrey R Idle; Frank J Gonzalez
Journal:  J Biol Chem       Date:  2011-04-12       Impact factor: 5.157

Review 4.  The role of dihydrosphingolipids in disease.

Authors:  Ruth R Magaye; Feby Savira; Yue Hua; Darren J Kelly; Christopher Reid; Bernard Flynn; Danny Liew; Bing H Wang
Journal:  Cell Mol Life Sci       Date:  2018-12-06       Impact factor: 9.261

Review 5.  Biomarkers in diabetic nephropathy: Present and future.

Authors:  Gemma Currie; Gerard McKay; Christian Delles
Journal:  World J Diabetes       Date:  2014-12-15

Review 6.  Metabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis.

Authors:  Marta Guasch-Ferré; Adela Hruby; Estefanía Toledo; Clary B Clish; Miguel A Martínez-González; Jordi Salas-Salvadó; Frank B Hu
Journal:  Diabetes Care       Date:  2016-05       Impact factor: 19.112

7.  Plasma amino acid and metabolite signatures tracking diabetes progression in the UCD-T2DM rat model.

Authors:  Brian D Piccolo; James L Graham; Kimber L Stanhope; Oliver Fiehn; Peter J Havel; Sean H Adams
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-04-19       Impact factor: 4.310

8.  Identification of phosphatidylcholine and lysophosphatidylcholine as novel biomarkers for cervical cancers in a prospective cohort study.

Authors:  Ming-Zhu Yin; Shu Tan; Xia Li; Yan Hou; Guosheng Cao; Kang Li; Junping Kou; Ge Lou
Journal:  Tumour Biol       Date:  2015-11-13

9.  Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study).

Authors:  F M van der Kloet; F W A Tempels; N Ismail; R van der Heijden; P T Kasper; M Rojas-Cherto; R van Doorn; G Spijksma; M Koek; J van der Greef; V P Mäkinen; C Forsblom; H Holthöfer; P H Groop; T H Reijmers; T Hankemeier
Journal:  Metabolomics       Date:  2011-02-24       Impact factor: 4.290

10.  Plasma metabolomic profiling of patients with diabetes-associated cognitive decline.

Authors:  Lin Zhang; Meng Li; Libin Zhan; Xiaoguang Lu; Lina Liang; Benli Su; Hua Sui; Zhengnan Gao; Yuzhong Li; Ying Liu; Benhui Wu; Qigui Liu
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.